Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators

Nutrients. 2023 Jul 26;15(15):3330. doi: 10.3390/nu15153330.


The androgen receptor (AR) is a member of the family of ligand-activated transcription factors. Selective androgen receptor modulators (SARMs) exert their biological function through complex interactions with the AR. It has been speculated that overexertion of AR signaling cascades as a result of SARM abuse can be a risk factor for the development of various cardiovascular diseases. The present literature review explores the implications of the interaction between SARMs and the AR on cardiovascular health by focusing on the AR structure, function, and mechanisms of action, as well as the current clinical literature on various SARMs. It is shown that SARMs may increase the risk of cardiovascular diseases through implications on the renin-angiotensin system, smooth muscle cells, sympathetic nervous system, lipid profile, inflammation, platelet activity, and various other factors. More research on this topic is necessary as SARM abuse is becoming increasingly common. There is a noticeable lack of clinical trials and literature on the relationship between SARMs, cardiovascular diseases, and the AR. Future in vivo and in vitro studies within this field are vital to understand the mechanisms that underpin these complex interactions and risk factors.

Keywords: SARMs; androgen receptor; androgen receptor signaling; atherosclerosis; cardiovascular disease; hypertension; myocardial hypertrophy; stroke.

Publication types

  • Review

MeSH terms

  • Androgen Receptor Antagonists
  • Androgens
  • Cardiovascular Diseases*
  • Humans
  • Ligands
  • Receptors, Androgen*


  • Receptors, Androgen
  • Androgens
  • Androgen Receptor Antagonists
  • Ligands

Grants and funding

This research received no external funding.